NOA articles & resources on Made-in-China.com

The US Patent and Trademark Office Has Granted a Notice of Allowance

Jan 15, 2013

The US Patent and Trademark Office (USPTO) has granted a notice of allowance (NOA) to biopharmaceutical company Amarin for its claims related to Vascepa and FDA-approved MARINE indication. The NOA, which is issued based on patent ...

Tags: NOA, Vascepa capsules, biopharmaceutical

Aphios Has Obtained NOA From USPTO for Its Patent Application for Oral Delivery of Insulin

Dec 19, 2012

Clinical stage biotechnology company Aphios has obtained notification of allowance(NOA)from the US Patent and Trademark Office(USPTO)for its patent application for oral delivery of insulin. The patent entitled'Polymer ...

Tags: Aphios, USPTO, oral delivery of insulin, NOA

A Noa Is Granted by USPTO to Echo Prelude Skinprep, Symphony Tcgm Systems

Dec 18, 2012

The US Patent and Trademark Office (USPTO) has granted a notice of allowance (NOA) to Echo Therapeutics' claimed application for its Prelude SkinPrep system and Symphony tCGM system. The claimed Patent Application No. 10/792,862 entitled ...

Tags: USPTO, NOA, application, notice of allowance, Prelude SkinPrep system

USPTO Has Granted a Noa to Sanovas' Nested Balloon Catheter for Localized Drug Delivery

Dec 18, 2012

The US Patent and Trademark Office (USPTO) has granted a notice of allowance (NOA) to Sanovas' minimally invasive nested balloon catheter for localized drug delivery. The patent will protect an integral part of the company's NanoVas ...

Tags: USPTO, NOA, minimally invasive nested balloon catheter, medical product

USPTO for a Patent Application No. 13/445,656 That Covers APL-130277

Dec 14, 2012

Specialty pharmaceutical company Cynapsus Therapeutics has received a Notice of Allowance from the US Patent and Trademark Office (USPTO) for a patent application No. 13/445,656 that covers APL-130277. Fast-acting APL-130277 is a thin ...

Tags: pharmaceutical products, apomorphine, APL-130277

USPTO Granted NOA to SkyePharma for a Patent Application 2012/0177734

Dec 5, 2012

The US Patent and Trademark Office (USPTO) has granted notice of allowance (NOA) to SkyePharma for a patent application 2012/0177734 of RAYOS (Prednisone) delayed-release tablets. The NOA covers the FDA-approved RAYOS, which uses the ...

Tags: SkyePharma, RAYOS delayed-release tablets, rheumatoid arthritis

USPTO Grants a Notice of Allowance to Arrowhead's Formulation of DPC siRNA Delivery System

Nov 28, 2012

The US Patent and Trademark Office (USPTO) has granted a notice of allowance (NOA) to Arrowhead Research's new formulation of dynamic polyconjugate (DPC) siRNA delivery system. The patent application No.13/032,029 covers claims for ...

Tags: siRNA delivery system, US Patent, dynamic polyconjugate, DPC platform

USPTO Has Granted a Notice of Allowance to Silence Therapeutics

Nov 27, 2012

The US Patent and Trademark Office(USPTO)has granted a Notice of Allowance(NOA)to Silence Therapeutics for claims related to interfering RNA molecules and lipid complexes used in drug delivery. The NOA,which is issued based on the ...

Tags: Silence Therapeutics, RNAi therapeutics, Silence Company, RNA molecules

NOA Is Granted by USPTO for Quick

Sep 14, 2012

The US Patent and Trademark Office (USPTO) has granted a notice of allowance (NOA) for Quick-Med Technologies' patent protecting new antimicrobial technology, Stay Fresh. The active antimicrobial agent utilizes non-toxic hydrogen peroxide ...

Tags: antimicrobial technology, Health

Noa for Disease-Modifying Therapeutic Agents Is Granted to Intellect Neurosciences

Aug 3, 2012

Intellect Neurosciences has won a notice of allowance (NOA) from the European Patent Office for its OX1, which has been licensed to ViroPharma for Friedrich's Ataxia and other neurodegenerative diseases. The OX1 patent relates to a new ...

Tags: neurodegenerative disease, patent, notice of allowance

NOA

Related Products